How Does Exparel Work? Mechanism of Action Explained in Plain English

Exparel provides up to 72 hours of pain relief from a single injection — but how does it actually do that? The secret lies in a clever drug delivery technology called DepoFoam. In this guide, we'll walk through exactly how Exparel works, from the chemistry of bupivacaine blocking nerve signals to how the liposome particles release the drug slowly over days.

Part 1: How Bupivacaine Blocks Pain

The active ingredient in Exparel is bupivacaine — a local anesthetic that belongs to a family of drugs called amide-type local anesthetics (along with lidocaine, ropivacaine, and mepivacaine). Here's how it blocks pain:

When your body experiences injury or trauma (like surgery), pain signals are generated by electrical impulses in nerve cells. These impulses travel along your nerves to your spinal cord and then to your brain, where they're perceived as pain.

Bupivacaine blocks these impulses by plugging sodium channels in nerve cell membranes. Sodium channels are tiny gates through which sodium ions flow to generate the electrical signal. When bupivacaine enters these channels and blocks them, the nerve can't fire. No electrical impulse = no pain signal reaching the brain.

This is the same mechanism used by standard bupivacaine (brand name: Marcaine), lidocaine (used at the dentist), and other local anesthetics. What makes Exparel different isn't the pharmacology of bupivacaine itself — it's the delivery system.

Part 2: The Problem With Standard Bupivacaine

Standard bupivacaine injected as a simple solution works beautifully — but it wears off in 4 to 8 hours. Once the drug diffuses away from the injection site and is absorbed into the bloodstream and metabolized by the liver, the nerve channels are no longer blocked and pain returns.

For most surgical procedures, meaningful pain occurs for 48–72 hours or longer after the operation. A local anesthetic that only lasts 4–8 hours covers maybe the first quarter of that window. That gap is typically filled with opioids — which come with their own risks of addiction, nausea, respiratory depression, and slowed recovery.

Pacira BioSciences set out to solve this problem with Exparel.

Part 3: DepoFoam — The Technology Behind Exparel

Exparel's extended-release effect comes from DepoFoam, a drug delivery platform that encapsulates bupivacaine inside multivesicular liposomes — specialized fat-based microscopic particles.

Here's how to picture it: imagine a honeycomb made of fatty lipid membranes. Each cell in the honeycomb is a tiny compartment containing a small amount of bupivacaine. The entire honeycomb structure is a single liposomal particle — and there are millions of them suspended in the Exparel injection.

The liposome particles range from about 24 to 31 micrometers in diameter — too large to enter blood vessels quickly, which is part of what slows the drug's release. After injection, the particles gradually erode and reorganize. As the lipid walls break down over time, bupivacaine is released from each compartment — first a small burst of free bupivacaine (from the outer surface of the particles), then a sustained release as the interior compartments open.

This biphasic release profile — an early burst followed by sustained slow release — is what provides pain relief for up to 72 hours from a single injection.

Part 4: What Happens to Bupivacaine After It's Released?

Once bupivacaine is released from the liposomes, it acts locally at the injection site — blocking the sodium channels in nearby nerve fibers. Over time, the free bupivacaine is absorbed into the bloodstream and distributed throughout the body.

Bupivacaine is highly protein-bound in the blood, which limits its activity away from the injection site. It's eventually metabolized by the liver (specifically CYP3A4 enzymes) and excreted in the urine. The mean elimination half-life is approximately 24–34 hours, but because the liposomes continue releasing drug over days, bupivacaine levels remain detectable for up to 96 hours.

Part 5: Why Lidocaine Shouldn't Be Mixed With Exparel

One of the most clinically important facts about Exparel is that it cannot be mixed with lidocaine or other non-bupivacaine local anesthetics. If lidocaine contacts the liposomes, it destabilizes the lipid membranes and causes an immediate, uncontrolled release of all the bupivacaine at once — potentially causing toxic blood levels.

For this reason, if lidocaine was used at the surgical site first (a common practice for wound anesthesia before incision), the team must wait at least 20 minutes before injecting Exparel to ensure the lidocaine has dissipated from the area. Bupivacaine HCl may be combined with Exparel, but the ratio of bupivacaine HCl to Exparel must not exceed 1:2 by milligram dose.

Summary: Exparel's Mechanism in Plain English

In plain English: Exparel is bupivacaine packed into tiny fat bubbles with honeycomb-like walls. Once injected, the bubbles slowly dissolve, releasing bupivacaine in a controlled way over 72 hours. The released bupivacaine blocks the sodium channels that nerve cells need to send pain signals, keeping the area numb for days — without opioids.

Ready to Learn More About Exparel?

If you're having surgery and want to understand all your options — including post-operative oral medications — medfinder is a paid service that can help you locate post-surgery prescriptions at pharmacies near you.

See also: What Is Exparel? Uses, Dosage, and What You Need to Know in 2026.

And: Exparel Drug Interactions: What to Avoid and What to Tell Your Doctor.